AIM Rule 26

The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies

ValiRx plc is listed on AIM of the London Stock Exchange under the ticker code VAL. There are no restrictions on the transfer of ValiRx’s shares and these are not listed on any other exchange.

These disclosures were last reviewed on the 25-08-2023.

AIM Securities Information

ValiRx plc is a company incorporated in the United Kingdom under the Companies Act 1985, it's “principal” place of business is in the United Kingdom.

UK City Code on Takeovers and Mergers:-  Valirx is subject to the UK City Code on Takeovers and Mergers.

The Total Number of AIM Securities in issue with nominal value of 0.1p is 102,319,610

The information below was last updated on 6 February 2023.

The percentage of AIM Securities not in public hands is approximately 23%.

Our Significant Shareholder(s)

Shareholder(s) with more than 3%

Shareholders Number of Shares Percentage of Total
Mr Adam Hargreaves 7,749,163 7.57%
Monecor (London) Ltd 4,466,969 4.37%

The Directors’ holding

Shareholders Number of Shares Percentage of Total
Directors (combined) 1,061,669 1.0%
Kevin Cox 372,333 0.36%
Gerry Desler 128,668 0.13%
Suzanne Dilly 416,668 0.41%
Martin Lampshire 144,000 0.14%



Joint Corporate Brokers

Cavendish Securities plc. One Bartholomew Close, London, EC1A 7BL Email:
Tel: +44 (0) 20 7397 8900

Turner Pope Investments (TPI) Limited.
6-8 Frederick's Place, London, EC2R 8AB
Tel: +44 (0) 20 3657 0050

Nominated Adviser

Cairn Financial Advisers LLP, Ninth Floor, 107 Cheapside, London, EC2V 6DN


Neville Registrars Limited, Neville House, Steelpark Road, Halesowen B62 8HD
Tel: +44 (0) 121585 1131


DACBeachcroft, 25 Walbrook, London, EC4N 8AF


Adler Shine, Aston House, Cornwall Avenue, Finchley, N3 1LF


The Co-operative Bank, PO Box 250, Delph House, Southway, Skelmersdale, WN8 6WT.

Corporate Governance

The Board of Directors is committed to applying high standards of corporate governance using the guidance of the QCA Code, revised in April 2018 as devised by the Quoted Companies Alliance.

The Corporate Governance sets out ValiRx’s compliance with the ten principles of the QCA Code, displaying how the company complies, and provides links to appropriate disclosures.

These arrangements are also disclosed in our Annual Report and Accounts.

These disclosures were last reviewed on the 25-08-2023.